2.15. Analysis.

Comparison 2 Conventional doxorubicin versus liposomalāencapsulated doxorubicin (myocet), Outcome 15 Adverse effects: infection grade >=3.

Comparison 2 Conventional doxorubicin versus liposomalāencapsulated doxorubicin (myocet), Outcome 15 Adverse effects: infection grade >=3.